Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 173

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults

Open access
Shah, Maunank, Hanrahan, Colleen, Wang, Zhuo Yu, Dendukuri, Nandini, Lawn, Stephen D, Denkinger, Claudia M, Steingart, Karen R · 2016 · Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: Rapid detection of tuberculosis (TB) among people living with human immunodeficiency virus (HIV) is a global health priority. HIV-associated TB may have different clinical presentations and is challenging to diagnose. Conventional sputum tests have reduced sensitivity in HIV-positive individuals, who have higher rates of extrapulmonary TB compared with HIV-negative individuals. The lateral flow urine lipoarabinomannan assay (LF-LAM) is a new, commercially available point-of-care test that detects lipoarabinomannan (LAM), a lipopolysaccharide present in mycobacterial cell walls, in people with active TB disease. OBJECTIVES: To assess the accuracy of LF-LAM for the diagnosis of active TB disease in HIV-positive adults who have signs and symptoms suggestive of TB (TB diagnosis).To assess the accuracy of LF-LAM as a screening test for active TB disease in HIV-positive adults irrespective of signs and symptoms suggestive of TB (TB screening). SEARCH METHODS: We searched the following databases without language restriction on 5 February 2015: the Cochrane Infectious Diseases Group Specialized Register; MEDLINE (PubMed,1966); EMBASE (OVID, from 1980); Science Citation Index Expanded (SCI-EXPANDED, from 1900), Conference Proceedings Citation Index-Science (CPCI-S, from 1900), and BIOSIS Previews (from 1926) (all three using the Web of Science platform; MEDION; LILACS (BIREME, from 1982); SCOPUS (from 1995); the metaRegister of Controlled Trials (mRCT); the search portal of the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP); and ProQuest Dissertations & Theses A&l (from 1861). SELECTION CRITERIA: Eligible study types included randomized controlled trials, cross-sectional studies, and cohort studies that determined LF-LAM accuracy for TB against a microbiological reference standard (culture or nucleic acid amplification test from any body site). A higher quality reference standard was one in which two or more specimen types were evaluated for TB, and a lower quality reference standard was one in which only one specimen type was evaluated for TB. Participants were HIV-positive people aged 15 years and older. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data from each included study using a standardized form. We appraised the quality of studies using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. We evaluated the test at two different cut-offs: (grade 1 or 2, based on the reference card scale of five intensity bands). Most analyses used grade 2, the manufacturer's currently recommended cut-off for positivity. We carried out meta-analyses to estimate pooled sensitivity and specificity using a bivariate random-effects model and estimated the models using a Bayesian approach. We determined accuracy of LF-LAM combined with sputum microscopy or Xpert® MTB/RIF. In addition, we explored the influence of CD4 count on the accuracy estimates. We assessed the quality of the evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. MAIN RESULTS: We included 12 studies: six studies evaluated LF-LAM for TB diagnosis and six studies evaluated the test for TB screening. All studies were cross-sectional or cohort studies. Studies for TB diagnosis were largely conducted among inpatients (median CD4 range 71 to 210 cells per µL) and studies for TB screening were largely conducted among outpatients (median CD4 range 127 to 437 cells per µL). All studies were conducted in low- or middle-income countries. Only two studies for TB diagnosis (33%) and one study for TB screening (17%) used a higher quality reference standard.LF-LAM for TB diagnosis (grade 2 cut-off): meta-analyses showed median pooled sensitivity and specificity (95% credible interval (CrI)) of 45% (29% to 63%) and 92% (80% to 97%), (five studies, 2313 participants, 35% with TB, low quality evidence). The pooled sensitivity of a combination of LF-LAM and sputum microscopy (either test positive) was 59% (47% to 70%), which represented a 19% (4% to 36%) increase over sputum microscopy alone, while the pooled specificity was 92% (73% to 97%), which represented a 6% (1% to 24%) decrease from sputum microscopy alone (four studies, 1876 participants, 38% with TB). The pooled sensitivity of a combination of LF-LAM and sputum Xpert® MTB/RIF (either test positive) was 75% (61% to 87%) and represented a 13% (1% to 37%) increase over Xpert® MTB/RIF alone. The pooled specificity was 93% (81% to 97%) and represented a 4% (1% to 16%) decrease from Xpert® MTB/RIF alone (three studies, 909 participants, 36% with TB). Pooled sensitivity and specificity of LF-LAM were 56% (41% to 70%) and 90% (81% to 95%) in participants with a CD4 count of less than or equal to 100 cells per µL (five studies, 859 participants, 47% with TB) versus 26% (16% to 46%) and 92% (78% to 97%) in participants with a CD4 count greater than 100 cells per µL (five studies, 141

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd011420.pub2

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 98

  1. Balcha, 2014, Detection of lipoarabinomannan in urine for identification of active tuberculosis among HIV-positive adults in Ethiopian health centres, Tropical Medicine & International Health, 19, 734, 10.1111/tmi.12308 · DOI
  2. Bjerrum, 2015, Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana- findings from the DETECT HIV-TB study, BMC Infectious Diseases, 15, 407, 10.1186/s12879-015-1151-1 · DOI
  3. Drain, 2014, Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study, BMC Infectious Diseases, 14, 110, 10.1186/1471-2334-14-110 · DOI
  4. Drain, 2015, Value of urine lipoarabinomannan grade and second test for optimising clinic-based screening for HIV-associated pulmonary tuberculosis, Journal of Acquired Immune Deficiency Syndromes, 68, 274, 10.1097/QAI.0000000000000436 · DOI
  5. Drain P Grobler A Gounder L Sahid F Wilson D Bassett I Rapid urine lipoarabinomannan testing after two months of tuberculosis treatment independently predicts mortality in a resource-limited setting 44th World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease Paris 2013 S264
  6. LaCourse, 2016, Active tuberculosis case finding in HIV-infected pregnant women in Kenya reveals poor performance of symptom screening and rapid diagnostic tests, Journal of Acquired Immune Deficiency Syndromes, 71, 219, 10.1097/QAI.0000000000000826 · DOI
  7. Lawn, 2012, Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study, Lancet Infectious Diseases, 12, 201, 10.1016/S1473-3099(11)70251-1 · DOI · Paper page
  8. Lawn SD Kerkhoff A Burton R Schutz C van Wyk G Vogt M Massive diagnostic yield of HIV-associated tuberculosis using rapid urine assays in South Africa Conference on Retroviruses and Opportunistic Infections (CROI) Boston (MA) 2014
  9. Nakiyingi, 2014, Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults, Journal of Acquired Immune Deficiency Syndromes, 66, 270, 10.1097/QAI.0000000000000151 · DOI
  10. Peter, 2012, Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients, European Respiratory Journal, 40, 1211, 10.1183/09031936.00201711 · DOI
  11. Peter, 2015, Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing, BMC Infectious Diseases, 15, 262, 10.1186/s12879-015-0967-z · DOI
  12. Achkar, 2011, Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration, Journal of Infectious Diseases, 204, S1130, 10.1093/infdis/jir450 · DOI
  13. Agha, 2013, Utility of quantitative analysis of urine lipoarabinomannan in the diagnosis of tuberculosis, Egyptian Journal of Chest Diseases and Tuberculosis, 62, 401, 10.1016/j.ejcdt.2013.06.007 · DOI
  14. Amoudy, 1997, Evaluation of complex and defined antigens of Mycobacterium tuberculosis in an IgG-specific ELISA for the diagnosis of tuberculosis, Medical Principles and Practice, 6, 103, 10.1159/000157434 · DOI
  15. Boehme, 2005, Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis, Transactions of the Royal Society of Tropical Medicine and Hygiene, 99, 893, 10.1016/j.trstmh.2005.04.014 · DOI · Paper page
  16. Boyles, 2012, The pros and cons of urinary lipoarabinomannan testing, AIDS, 26, 2263-4; author, 10.1097/QAD.0b013e3283573286 · DOI
  17. Chan, 2000, Diagnosis of tuberculosis by a visually detectable immunoassay for lipoarabinomannan, American Journal of Respiratory and Critical Care Medicine, 161, 1713, 10.1164/ajrccm.161.5.9908125 · DOI
  18. Cho, 1997, Detection of Mycobacterium tuberculosis antigens in sputum for the diagnosis of pulmonary tuberculosis, Journal of the Korean Society for Microbiology, 32, 285
  19. Conesa-Botella, 2011, Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome, Journal of Acquired Immune Deficiency Syndromes, 58, 463, 10.1097/QAI.0b013e31823801de · DOI
  20. Daley, 2009, Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study, International Journal of Tuberculosis and Lung Disease, 13, 989
  21. Deng, 2011, Clinical utility of a combination of lipoarabinomannan, 38-kDa, and 16-kDa antigens as a diagnosis tool for tuberculosis, Diagnostic Microbiology and Infectious Disease, 71, 46, 10.1016/j.diagmicrobio.2011.04.015 · DOI
  22. Dheda, 2009, Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting, PLoS One, 4, e4689, 10.1371/journal.pone.0004689 · DOI
  23. Dheda, 2010, Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples, PLoS One, 5, e9848, 10.1371/journal.pone.0009848 · DOI
  24. Elsawy, 2012, Urine lipoarabinomannan as initial markers for active pulmonary tuberculosis, Australian Journal of Basic and Applied Sciences, 6, 751
  25. Gounder, 2011, Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis, Journal of Acquired Immune Deficiency Syndromes, 58, 219, 10.1097/QAI.0b013e31822b75d4 · DOI
  26. Hamasur, 2001, Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine, Journal of Microbiological Methods, 45, 41, 10.1016/S0167-7012(01)00239-1 · DOI
  27. Hanrahan, 2012, Urine antigen test for diagnosis of HIV-associated tuberculosis, The Lancet Infectious Diseases, 12, 826, 10.1016/S1473-3099(12)70219-0 · doi:10.1016/s1473-3099(12)70219-0
  28. Kashino, 2008, Identification and characterization of Mycobacterium tuberculosis antigens in urine of patients with active pulmonary tuberculosis: an innovative and alternative approach of antigen discovery of useful microbial molecules, Clinical and Experimental Immunology, 153, 56, 10.1111/j.1365-2249.2008.03672.x · DOI
  29. Kerkhoff, 2014, Predictive value of anaemia for tuberculosis in HIV-infected patients in sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays, Journal of Acquired Immune Deficiency Syndromes, 66, 33, 10.1097/QAI.0000000000000091 · DOI
  30. Kerkhoff, 2014, Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis, PLoS One, 9, e103285, 10.1371/journal.pone.0103285 · DOI
  31. Koulchin, 2007, Evaluation of the detection of urinary lipoarabinomannan as a tool for diagnosis of mycobacterial infections, Abstracts of the General Meeting of the American Society for Microbiology, 107, 174
  32. Kroidl, 2014, Reasons for false-positive lipoarabinomannan ELISA results in a Tanzanian population, Scandinavian Journal of Infectious Diseases, 46, 144, 10.3109/00365548.2013.853133 · DOI
  33. Lawn, 2009, Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease, AIDS, 23, 1875, 10.1097/QAD.0b013e32832e05c8 · DOI · Paper page
  34. Lawn, 2012, Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review, BMC Infectious Diseases, 12, 103, 10.1186/1471-2334-12-103 · DOI · Paper page
  35. Lawn, 2012, Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis, AIDS, 26, 1635, 10.1097/QAD.0b013e3283553685 · DOI
  36. Lawn, 2012, Point-of-care urine antigen screening tests for tuberculosis and cryptococcosis: potential for mortality reduction in antiretroviral treatment programs in Africa, Clinical Infectious Diseases, 54, 739, 10.1093/cid/cir908 · doi:10.1093/cid/cir908
  37. Lawn, 2013, HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays, BMC Medicine, 11, 231, 10.1186/1741-7015-11-231 · DOI
  38. Lawn, 2014, Underestimation of the incremental diagnostic yield of HIV-associated tuberculosis in studies of the Determine TB-LAM Ag urine assay, AIDS, 28, 1846, 10.1097/QAD.0000000000000305 · doi:10.1097/qad.0000000000000305
  39. Manabe, 2014, Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda, PLoS One, 9, e101459, 10.1371/journal.pone.0101459 · DOI
  40. Mukundan, 2012, Rapid detection of Mycobacterium tuberculosis biomarkers in a sandwich immunoassay format using a waveguide-based optical biosensor, Tuberculosis (Edinburgh, Scotland), 92, 407, 10.1016/j.tube.2012.05.009 · DOI
  41. Mutetwa, 2009, Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients, International Journal of Tuberculosis and Lung Disease, 13, 1253
  42. Patel, 2009, Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting, Cerebrospinal Fluid Research, 6, 13, 10.1186/1743-8454-6-13 · DOI
  43. Patel, 2010, Comparison of a clinical prediction rule and a LAM antigen-detection assay for the rapid diagnosis of TBM in a high HIV prevalence setting, PLoS One, 5, e15664, 10.1371/journal.pone.0015664 · DOI
  44. Peter, 2011, The clinical utility of urine lipoarabinomannan and the novel point-of-care lateral flow strip test (Determine TB) for the diagnosis of tuberculosis in hospitalised patients with HIV-related advanced immunosuppression, American Journal of Respiratory and Critical Care Medicine Conference: American Thoracic Society International Conference, ATS, 183, A5313
  45. Peter, 2012, Diagnostic accuracy of induced sputum LAM ELISA for tuberculosis diagnosis in sputum-scarce patients, International Journal of Tuberculosis and Lung Disease, 16, 1108, 10.5588/ijtld.11.0614 · DOI
  46. Peter, 2012, The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalised patients who are smear-negative or sputum scarce, PLoS One, 7, e39966, 10.1371/journal.pone.0039966 · DOI
  47. Peter, 2013, Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?, PLoS One, 8, e54875, 10.1371/journal.pone.0054875 · DOI
  48. Reither, 2009, Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis, BMC Infect Diseases, 9, 141, 10.1186/1471-2334-9-141 · DOI
  49. Sada, 1992, Detection of lipoarabinomannan as a diagnostic test for tuberculosis, Journal of Clinical Microbiology, 30, 2415, 10.1128/JCM.30.9.2415-2418.1992 · DOI
  50. Savolainen, 2013, Modification of Clearview tuberculosis (TB) enzyme-linked immunosorbent assay for TB patients not infected with HIV, Clinical and Vaccine Immunology, 20, 1479, 10.1128/CVI.00375-13 · DOI
  51. Schmidt, 2011, Single-molecule detection on a protein-array assay platform for the exposure of a tuberculosis antigen, Journal of Proteome Research, 10, 1316, 10.1021/pr101070j · DOI
  52. Shah, 2009, Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalised patients in a high HIV prevalence setting, Journal of Acquired Immune Deficiency Syndromes, 52, 145, 10.1097/QAI.0b013e3181b98430 · DOI
  53. Shah, 2010, Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis, Journal of Clinical Microbiology, 48, 2972, 10.1128/JCM.00363-10 · DOI
  54. Shah, 2013, Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda, AIDS, 27, 2883, 10.1097/QAD.0000000000000008 · DOI
  55. Shah, 2014, Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals, AIDS, 28, 1307, 10.1097/QAD.0000000000000264 · DOI
  56. Singh, 2011, Detection of TB antigen by rapid test kit, Medical Journal Armed Forces India, 67, 196, 10.1016/S0377-1237(11)60038-5 · DOI
  57. Sun, 2013, Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults, International Journal of Tuberculosis and Lung Disease, 17, 552, 10.5588/ijtld.12.0627 · DOI
  58. Swaminathan, 2012, Antigen detection as a point-of-care test for TB: the case of lipoarabinomannan, Future Microbiology, 7, 559, 10.2217/fmb.12.34 · doi:10.2217/fmb.12.34
  59. Talbot, 2012, Test characteristics of urinary lipoarabinomannan and predictors of mortality among hospitalised HIV-infected tuberculosis suspects in Tanzania, PLoS One, 7, e32876, 10.1371/journal.pone.0032876 · doi:10.1371/journal.pone.0032876
  60. Tessema, 2001, Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre, Scandinavian Journal of Infectious Diseases, 33, 279, 10.1080/003655401300077306 · DOI
  61. Tessema, 2002, Clinical and radiological features in relation to urinary excretion of lipoarabinomannan in Ethiopian tuberculosis patients, Scandinavian Journal of Infectious Diseases, 34, 167, 10.1080/00365540110077254 · DOI
  62. Tessema, 2002, Circulating antibodies to lipoarabinomannan in relation to sputum microscopy, clinical features and urinary anti-lipoarabinomannan detection in pulmonary tuberculosis, Scandinavian Journal of Infectious Diseases, 34, 97, 10.1080/00365540110077263 · DOI
  63. Tlali M Fielding K Charalambous S Karat A Hoffmann C Johnson S Sensitivity of the TB Determine LAM test compared to sputum culture gold standard TB in ambulant HIV positive participants enrolled in the TB fast track study in South Africa 4th South African TB Conference Durban 2014
  64. Van Rie A Jong E Mkhwanazi M Sanne I Diagnosing TB in those hardest to diagnose: urine lipoarabinomannan for suspects of disseminated and extrapulmonary TB Conference on Retroviruses and Opportunistic Infections (CROI) Atlanta (GA) 2013 443
  65. Wood, 2012, Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria, BMC Infect Diseases, 12, 47, 10.1186/1471-2334-12-47 · DOI
  66. Bartlett, 2007, Tuberculosis and HIV infection: partners in human tragedy, Journal of Infectious Diseases, 196, S124, 10.1086/518668 · doi:10.1086/518668
  67. Cain, 2010, An algorithm for tuberculosis screening and diagnosis in people with HIV, New England Journal of Medicine, 362, 707, 10.1056/NEJMoa0907488 · DOI · Paper page
  68. Chu, 2009, Random effects models in a meta-analysis of the accuracy of two diagnostic tests without a gold standard, Journal of the American Statistical Association, 104, 512, 10.1198/jasa.2009.0017 · DOI
  69. Dowdy D A review of cost-effectiveness analyses of LF-LAM for TB diagnosis among people living with HIV [personal communication] Email to: M Shah.
  70. Drain, 2015, Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study, BMJ Open, 5, e006833, 10.1136/bmjopen-2014-006833 · DOI
  71. Getahun, 2007, Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes, Lancet, 369, 2042, 10.1016/S0140-6736(07)60284-0 · DOI · Paper page
  72. Getahun, 2011, Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies, PLoS Medicine, 8, e1000391, 10.1371/journal.pmed.1000391 · DOI · Paper page
  73. Gupta, 2015, Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis, AIDS, 29, 1987, 10.1097/QAD.0000000000000802 · DOI · Paper page
  74. Havlir, 2008, Opportunities and challenges for HIV care in overlapping HIV and TB epidemics, Journal of the American Medical Association, 300, 423, 10.1001/jama.300.4.423 · DOI
  75. Lawn, 2013, Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies, BMC Infectious Diseases, 13, 407, 10.1186/1471-2334-13-407 · DOI
  76. Lawn, 2015, Underestimation of the true specificity of the urine lipoarabinomannan (LAM) point-of-care diagnostic assay for HIV-associated tuberculosis, Journal of Acquired Immune Deficiency Syndromes, 69, e144, 10.1097/QAI.0000000000000672 · DOI
  77. Lunn, 2000, WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility, Statistics and Computing, 10, 325, 10.1023/A:1008929526011 · DOI · Paper page
  78. Macaskill P Gatsonis C Deeks JJ Harbord RM Takwoingi Y Chapter 10: Analysing and Presenting Results. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors), Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration, 2010 Available from http://srdta.cochrane.org/
  79. Minion, 2011, Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis, European Respiratory Journal, 38, 1398, 10.1183/09031936.00025711 · DOI · Paper page
  80. Novielli, 2013, Meta-analysis of the accuracy of two diagnostic tests used in combination: application to the ddimer test and the wells score for the diagnosis of deep vein thrombosis, Value Health, 16, 619, 10.1016/j.jval.2013.02.007 · DOI
  81. Pai, 2012, Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs, Discovery Medicine, 13, 35
  82. Perkins, 2007, Facing the crisis: improving the diagnosis of tuberculosis in the HIV era, Journal of Infectious Diseases, 196, S15, 10.1086/518656 · DOI · Paper page
  83. Peter, 2010, Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments, Current Opinion of Pulmonary Medicine, 16, 262, 10.1097/MCP.0b013e328337f23a · DOI
  84. Peter, 2012, Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients, European Respiratory Journal, 40, 1211, 10.1183/09031936.00201711 · DOI
  85. Peter, 2016, Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial, Lancet, 387, 1187, 10.1016/S0140-6736(15)01092-2 · DOI · Paper page
  86. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
  87. Siddiqi, 2003, Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence, Lancet Infectious Diseases, 3, 288, 10.1016/S1473-3099(03)00609-1 · DOI · Paper page
  88. Steingart, 2006, Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review, Lancet Infectious Diseases, 6, 570, 10.1016/S1473-3099(06)70578-3 · DOI · Paper page
  89. Steingart, 2014, Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD009593.pub3 · DOI · Paper page
  90. Trikalinos, 2014, An empirical comparison of univariate and multivariate meta-analyses for categorical outcomes, Statistics in Medicine, 33, 1441, 10.1002/sim.6044 · DOI
  91. Vacek, 1985, The effect of conditional dependence on the evaluation of diagnostic tests, Biometrics, 41, 959, 10.2307/2530967 · DOI · Paper page
  92. Weyer, 2011, Viewpoint TB diagnostics: what does the world really need?, Journal of Infectious Diseases, 204, S1196, 10.1093/infdis/jir452 · DOI
  93. Whalen, 1995, Accelerated course of human immunodeficiency virus infection after tuberculosis, American Journal of Respiratory and Critical Care Medicine, 151, 129, 10.1164/ajrccm.151.1.7812542 · DOI · Paper page
  94. World Health Organization, 2015, Global tuberculosis report 2015. WHO/HTM/TB/2015.22
  95. World Health Organization, 2015, The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV. Policy guidance. WHO/HTM/TB/2015.25
  96. World Health Organization, 2013, Systematic screening for active tuberculosis: principles and recommendations. WHO/HTM/TB/2013.04
  97. World Health Organization, 2013, Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. WHO/HTM/TB/2013.16
  98. Shah, 2014, Urine lateral flow lipoarabinomannan assay for diagnosing active tuberculosis in adults living with HIV, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD011420 · DOI

Cited by

See all 173

Metadata

Authors
Shah, M., Hanrahan, C., Wang, Z. Y., Dendukuri, N., Lawn, S. D., Denkinger, C. M., & Steingart, K. R.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2016-05-10
Issue
5
Pages
CD011420-CD011420
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W2369312856
Cited by
173
References
5
FWCI
24.36
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults. https://app.cochat.ai/papers/10.1002/14651858.cd011420.pub2
The paper
Shah, M., Hanrahan, C., Wang, Z. Y., Dendukuri, N., Lawn, S. D., Denkinger, C. M., & Steingart, K. R. (2016). Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd011420.pub2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.